| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 18.16B | 17.27B | 13.22B | 10.96B | 9.16B | 7.60B |
| Gross Profit | 12.30B | 11.82B | 9.72B | 8.31B | 7.07B | 5.91B |
| EBITDA | 3.62B | 3.35B | 2.77B | 2.64B | 2.15B | 1.11B |
| Net Income | 2.28B | 2.09B | 1.79B | 1.67B | 1.34B | 552.59M |
Balance Sheet | ||||||
| Total Assets | 18.02B | 15.64B | 11.59B | 9.76B | 8.83B | 8.15B |
| Cash, Cash Equivalents and Short-Term Investments | 2.12B | 2.35B | 1.44B | 1.20B | 1.02B | 1.10B |
| Total Debt | 4.15B | 2.35B | 1.27B | 1.41B | 2.06B | 3.01B |
| Total Liabilities | 11.84B | 9.73B | 6.96B | 6.30B | 6.46B | 6.95B |
| Stockholders Equity | 6.18B | 5.92B | 4.63B | 3.46B | 2.37B | 1.21B |
Cash Flow | ||||||
| Free Cash Flow | 345.58M | 1.76B | 1.15B | 1.43B | 1.09B | 769.30M |
| Operating Cash Flow | 488.28M | 2.06B | 1.36B | 1.56B | 1.34B | 847.38M |
| Investing Cash Flow | -574.70M | -1.28B | -346.57M | -153.98M | -288.79M | -123.38M |
| Financing Cash Flow | 180.24M | 135.19M | -777.68M | -1.23B | -1.13B | -599.74M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥57.85B | 9.84 | ― | 0.45% | 15.55% | 124.87% | |
76 Outperform | ¥20.04B | -32.07 | ― | 3.54% | 10.04% | 11.33% | |
72 Outperform | ¥24.16B | 10.94 | ― | 3.29% | 31.68% | 12.73% | |
71 Outperform | ¥8.06B | 30.59 | ― | 5.03% | 18.20% | 75.69% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
62 Neutral | ¥72.47B | 8.53 | ― | 2.89% | 33.75% | -0.68% | |
58 Neutral | ¥207.14B | 9.79 | 20.50% | 1.49% | 2.44% | -71.52% |